Skip to main content
Top
Published in: Journal of Ophthalmic Inflammation and Infection 1/2016

Open Access 01-12-2016 | Original research

A national survey of Canadian ophthalmologists to determine awareness of published guidelines for the management of uveitis

Authors: Crystal S. Y. Cheung, Nima Noordeh, Chloe C. Gottlieb

Published in: Journal of Ophthalmic Inflammation and Infection | Issue 1/2016

Login to get access

Abstract

Background

The objectives of this study are to assess Canadian ophthalmologists’ awareness of established uveitis treatment guidelines and clinical management of uveitis and to assess the frequency of government applications for immunomodulatory therapy (IMT) and identify primary prescribers.
A 25-item questionnaire was sent to 759 practicing Canadian ophthalmologists. Six questions assessed demographics including the year of residency completion, training by uveitis specialists during residency, and fellowship training. Five questions assessed application of guidelines to clinical scenarios, and 12 questions assessed referral patterns and success of obtaining coverage for IMT.

Results

Of 144 respondents, 12 (8.3 %) were uveitis specialists; 45.1 % of respondents had uveitis training during residency by a uveitis specialist. Sixty-one percent reported awareness of management guidelines. Recent graduates (2001–2012) referred patients to uveitis specialists (55.3 %) less frequently than earlier graduates. Recent graduates also managed uveitis patients more frequently with corticosteroid injections (15.6 %) than those who graduated before 1980 (9.75 %). The majority (93.6 %) of respondents submitted less than six IMT funding applications for provincial drug coverage yearly, and 5.5 % reported prescribing IMT themselves, rather than referring to other specialists.

Conclusions

Although greater than half of respondents reported awareness of uveitis treatment guidelines, Canadian ophthalmologists’ awareness of uveitis treatment guidelines and application of the guidelines to patient care could be improved. Few applications are made for IMT, and the majority of applications are sent by non-ophthalmologists. This suggests the need for further education of ophthalmologist about uveitis treatment guidelines and for more ophthalmologists trained to manage uveitis with IMT.
Appendix
Available only for authorised users
Literature
2.
go back to reference Jabs DA, Nussenblatt RB, Rosenbaum JT (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140(3):509–516CrossRefPubMed Jabs DA, Nussenblatt RB, Rosenbaum JT (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140(3):509–516CrossRefPubMed
4.
go back to reference Durrani K, Zakka FR, Ahmed M et al (2011) Systemic therapy with conventional and novel immunomodulatory agents for ocular inflammation disease. Surv Ophthalmol 56:474–510CrossRefPubMed Durrani K, Zakka FR, Ahmed M et al (2011) Systemic therapy with conventional and novel immunomodulatory agents for ocular inflammation disease. Surv Ophthalmol 56:474–510CrossRefPubMed
5.
go back to reference Jabs DA, Rosenbaum JT, Foster CS et al (2000) Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol 130:492–513CrossRefPubMed Jabs DA, Rosenbaum JT, Foster CS et al (2000) Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol 130:492–513CrossRefPubMed
6.
go back to reference Nguyen QD, Hatef E, Kayen B et al (2011) A cross-sectional study of the current treatment patterns in non-infectious uveitis among specialists in the United States. Ophthalmology 118:184–190CrossRefPubMed Nguyen QD, Hatef E, Kayen B et al (2011) A cross-sectional study of the current treatment patterns in non-infectious uveitis among specialists in the United States. Ophthalmology 118:184–190CrossRefPubMed
8.
go back to reference Lowder C, Belfort R, Lightman S et al (2011) Dexamethasone intravitreal implant for non-infectious intermediate or posterior uveitis. Arch Ophthalmol 129:545–553CrossRefPubMed Lowder C, Belfort R, Lightman S et al (2011) Dexamethasone intravitreal implant for non-infectious intermediate or posterior uveitis. Arch Ophthalmol 129:545–553CrossRefPubMed
9.
go back to reference McCannel CA, Holland GN, Helm CJ et al (1996) Causes of uveitis in the general practice of ophthalmology. UCLA Community-Based Uveitis Study Group. Am J Ophthalmol 121:35–46CrossRefPubMed McCannel CA, Holland GN, Helm CJ et al (1996) Causes of uveitis in the general practice of ophthalmology. UCLA Community-Based Uveitis Study Group. Am J Ophthalmol 121:35–46CrossRefPubMed
10.
go back to reference Chan SM, Hudson M, Weis E (2007) Anterior and intermediate uveitis cases referred to a tertiary centre in Alberta. Can J Ophthalmol 42:860–864CrossRefPubMed Chan SM, Hudson M, Weis E (2007) Anterior and intermediate uveitis cases referred to a tertiary centre in Alberta. Can J Ophthalmol 42:860–864CrossRefPubMed
11.
go back to reference Sakai JL, Usui Y, Sakai M et al (2010) Clinical statistics of endogenous uveitis: comparison between general eye clinic and university hospital. Int Ophthalmol 30:297–301CrossRefPubMed Sakai JL, Usui Y, Sakai M et al (2010) Clinical statistics of endogenous uveitis: comparison between general eye clinic and university hospital. Int Ophthalmol 30:297–301CrossRefPubMed
12.
go back to reference Zhou AW, Noble J, Lam WC (2009) Canadian ophthalmology residency training: an evaluation of resident satisfaction and comparison with international standards. Can J Ophthalmol 44:540–547CrossRefPubMed Zhou AW, Noble J, Lam WC (2009) Canadian ophthalmology residency training: an evaluation of resident satisfaction and comparison with international standards. Can J Ophthalmol 44:540–547CrossRefPubMed
13.
go back to reference Forooghian F, Gupta R, Wong D et al (2006) Anterior uveitis investigation by Canadian ophthalmologists: insights from the Canadian National Uveitis Survey. Can J Ophthalmol 41:576–583CrossRefPubMed Forooghian F, Gupta R, Wong D et al (2006) Anterior uveitis investigation by Canadian ophthalmologists: insights from the Canadian National Uveitis Survey. Can J Ophthalmol 41:576–583CrossRefPubMed
14.
go back to reference Peyman GA, Lad EM, Moshfeghi DM (2009) Intravitreal injection of therapeutic agents. Retina 29:875–912CrossRefPubMed Peyman GA, Lad EM, Moshfeghi DM (2009) Intravitreal injection of therapeutic agents. Retina 29:875–912CrossRefPubMed
15.
go back to reference Haller JA, Bandello F, Belfort R Jr et al (2010) Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 117:1134.e3–1146.e3CrossRef Haller JA, Bandello F, Belfort R Jr et al (2010) Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 117:1134.e3–1146.e3CrossRef
16.
go back to reference Cunningham ET Jr, Wender JD (2010) Practical approach to the use of corticosteroids in patients with uveitis. Can J Ophthalmol 45:352–358CrossRefPubMed Cunningham ET Jr, Wender JD (2010) Practical approach to the use of corticosteroids in patients with uveitis. Can J Ophthalmol 45:352–358CrossRefPubMed
17.
go back to reference Gregory AC II, Kempen JH, Daniel E et al (2013) Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Disease Study. Ophthalmology 120:186–192CrossRefPubMed Gregory AC II, Kempen JH, Daniel E et al (2013) Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Disease Study. Ophthalmology 120:186–192CrossRefPubMed
18.
go back to reference Samson CM, Waheed M, Baltatzis S et al (2001) Methotrexate therapy for chronic noninfectious uveitis. Ophthalmology 108:1134–1139CrossRefPubMed Samson CM, Waheed M, Baltatzis S et al (2001) Methotrexate therapy for chronic noninfectious uveitis. Ophthalmology 108:1134–1139CrossRefPubMed
19.
go back to reference Esterberg E, Acharya NR (2012) Corticosteroid-sparing therapy: practice patterns among uveitis specialists. J Ophthalmic Inflamm Infect 2:21–28CrossRefPubMed Esterberg E, Acharya NR (2012) Corticosteroid-sparing therapy: practice patterns among uveitis specialists. J Ophthalmic Inflamm Infect 2:21–28CrossRefPubMed
Metadata
Title
A national survey of Canadian ophthalmologists to determine awareness of published guidelines for the management of uveitis
Authors
Crystal S. Y. Cheung
Nima Noordeh
Chloe C. Gottlieb
Publication date
01-12-2016
Publisher
Springer Berlin Heidelberg
Published in
Journal of Ophthalmic Inflammation and Infection / Issue 1/2016
Electronic ISSN: 1869-5760
DOI
https://doi.org/10.1186/s12348-016-0102-3

Other articles of this Issue 1/2016

Journal of Ophthalmic Inflammation and Infection 1/2016 Go to the issue